PXR, when activated, has been shown to be sufficient at enhancing neoplastic characteristics including: cell growth, invasion, and metastasis through activation of Fibroblast Growth Factor 19 (FGF19) gene expression in colon cancer. This evidence concerns the gene NR1I2 and colonic neoplasm.